Anticancer treatment using triptolide prodrugs

Details for Australian Patent Application No. 2002237884 (hide)

Owner Pharmagenesis, Inc.

Inventors Fidler, John, M.; Li, Ke

Agent FB Rice

Pub. Number AU-B-2002237884

PCT Pub. Number WO2002/056835

Priority 09/766,156 19.01.01 US

Filing date 18 January 2002

Wipo publication date 30 July 2002

Acceptance publication date 17 August 2006

International Classifications

A61K 31/34 (2006.01) - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-B-2002237884

17 August 2006 Application Accepted

  Published as AU-B-2002237884

14 December 2006 Standard Patent Sealed

13 August 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002237885-FRAME HANDLING FOR A THIN CLIENT

2002237883-SPEAKER SURROUND STRUCTURE FOR MAXIMIZING CONE DIAMETER